ANAPTYSBIO CEO Hamza Suria's 2019 pay jumps 54% to $7.9M
ANAPTYSBIO reports 2019 executive compensation
By ExecPay News
Published: April 27, 2020
ANAPTYSBIO reported fiscal year 2019 executive compensation information on April 27, 2020.
In 2019, four ANAPTYSBIO executives received on average a compensation package of $4.1M, a 37% increase compared to previous year.
Average pay of disclosed executives at ANAPTYSBIO
Hamza Suria, Chief Executive Officer, received $7.9M in total, which increased by 54% compared to 2018. 93% of Suria's compensation, or $7.3M, was in option awards. Suria also received $567K in salary and $6.5K in other compensation.
Eric Loumeau, Chief Financial Officer, received a compensation package of $3.5M, which increased by 64% compared to previous year. 86% of the compensation package, or $3.1M, was in option awards.
Marco Londei, Chief Medical Officer, earned $3.1M in 2019, a 23% increase compared to previous year.
Dominic Piscitelli, Chief Financial Officer, received $1.9M in 2019, which decreases by 12% compared to 2018.
Related executives
You may also like
Source: SEC filing on April 27, 2020.